Company Tonix Pharmaceuticals Holding Corp Nasdaq
Equities
US8902604094
Pharmaceuticals
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Therapeutics
100.0
%
| 0 | nan % | 8 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 8 | 100.0 % | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 95,543,805 | 95,538,605 ( 99.99 %) | 0 | 99.99 % |
Company contact information
Tonix Pharmaceuticals Holding Corp.
26 Main Street Suite 101
07928, Chatham
+862 799 8599
http://www.tonixpharma.comSector
1st Jan change | Capi. | |
---|---|---|
-3.54% | 90.45B | |
+3.95% | 41.45B | |
-10.51% | 33.57B | |
+60.58% | 25.73B | |
-20.09% | 14.73B | |
-8.92% | 12.82B | |
-11.46% | 11.7B | |
-43.05% | 11.44B | |
+5.17% | 8.79B |